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Abstract
Background: Malaria is a significant public health concern in Haiti where approximately 30,000 cases are reported
annually with CDC estimates as high as 200,000. Malaria infections in Haiti are caused almost exclusively by
Plasmodium falciparum, while a small number of Plasmodium malariae and an even smaller number of putative
Plasmodium vivax infections have been reported. The lack of confirmed P. vivax infections in Haiti could be due to
the genetic background of native Haitians. Having descended from West African populations, many Haitians could
be Duffy negative due to a single nucleotide polymorphism from thymine to cytosine in the GATA box of the
promoter region of the Duffy antigen receptor for chemokines (DARC) gene. This mutation, encoded by the FYES
allele, eliminates the expression of the Duffy antigen on erythrocytes, which reduces invasion by P. vivax. This study
investigated the frequency of the FYES allele and P. vivax infections in malaria patients with the goal of uncovering
factors for the lack of P. vivax infections reported in Haiti.
Methods: DNA was extracted from dried blood spots collected from malaria patients at four clinic locations in
Haiti. The samples were analysed by polymerase chain reaction (PCR) for the presence of the P. vivax small subunit
ribosomal RNA gene. PCR, sequencing, and restriction enzyme digestion were used to detect the presence of the
FYES allele. Matched samples were examined for both presence of P. vivax and the FYES allele.
Results: No cases of P. vivax were detected in any of the samples (0/136). Of all samples tested for the FYES allele,
99.4% had the FYES allele (163/164). Of the matched samples, 99% had the FYES allele (98/99).
Conclusions: In this preliminary study, no cases of P. vivax were confirmed by PCR and 99% of the malaria patients
tested carried the FYES allele. The high frequency of the FYES allele that silences erythroid expression of the Duffy
antigen offers a biologically plausible explanation for the lack of P. vivax infections observed. These results provide
insights on the host susceptibility for P. vivax infections that has never before been investigated in Haiti.
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Background
Malaria transmission in Haiti is a serious public health
concern where approximately 30,000 cases are reported
each year with Centers for Disease Control and Prevention
(CDC) estimates as high as 200,000 [1]. Over 99% of mal-
aria infections in Haiti are caused by Plasmodium falcip-
arum, with less than 1% of cases reported as Plasmodium
malariae infections [2-4]. There are even fewer reports of
Plasmodium vivax in Haiti, all of which were only
detected by microscopy and none confirmed by polymer-
ase chain reaction (PCR) based methodologies [2,5,6].
Since P. vivax is responsible for 74% of all cases of malaria
in Central and South America and up to 94% of cases in
Mexico and Central America, the lack of P. vivax infec-
tions in Haiti merits further investigation [1,5,7]. Besides
geographical isolation, host genetic factors could be an-
other reason for the lack of P. vivax infections in Haiti. A
majority of Haitians are descendants of West African
populations, who have a high frequency of individuals that
do not express the Duffy antigen receptor for chemokines
(DARC) on their erythrocytes [8,9]. The absence of the
Duffy antigen on erythrocytes has been shown to reduce
or completely prevent P. vivax infections [10-14].
The Duffy antigen is a trans-membrane glycoprotein
located on red blood cells that contains a N-terminal domain
used by P. vivaxmerozoites to invade and infect erythrocytes
[15,16]. There are two co-dominant alleles FYA and FYB that
differ by a single nucleotide at amino acid codon 42, where a
change from glycine to aspartic acid results in the expression
of the Fya or Fyb antigen, respectively [17]. In many African
and African-descendent populations the expression of the
Duffy antigen is silenced as a result of a single nucleotide
polymorphism (SNP) in the GATA box sequence in the
DARC gene promoter region in which a cytosine (C)
replaces thymine (T) 46 nucleotides before the erythroid cap
site [18-20]. This erythroid silent (ES) genotype, encoded by
the FYES allele, is responsible for the Duffy negative pheno-
type expressed by homozygotes that can reach a population
frequency of 100% in native West Africans [9,21].
Neither the reason why P. vivax has been so rarely
observed in Haitians, nor the prevalence of the erythroid
silent Duffy antigen genotype has been investigated in
detail. Therefore, this study investigated the frequency of
the FYES allele and P. vivax infections in malaria
patients. The information obtained from this study will
help clarify the status of P. vivax infections in Haiti.
Methods
Data collection
Dried blood samples (DBS) were collected by finger prick
and blotted on filter paper (FTA cards, Whatman©) in
Haiti from May 2010 to August 2012. The samples origi-
nated from several clinics including the Blanchard clinic
in Port-au-Prince (n = 164), Hinche (n = 7), Cap-Haitien
(n = 7), and Jacmel (n = 6) (Figure 1). Samples from
patients at the Blanchard clinic included symptomatic
individuals as well as those confirmed by rapid test and/or
microscopy to have P. falciparum or mixed infections
(P. falciparum and P. malariae or P. vivax). Samples from
patients at the other three locations were confirmed by mi-
croscopy alone. The DBS were transported to the Emerging
Pathogens Institute at the University of Florida and
archived in dry storage before further genetic analyses
as described below.
DNA extraction
A methanol extraction procedure was used to extract
the DNA from the DBS [22]. Three millimetre discs were
punched from the DBS, placed inside a PCR tube, and
100 μl of absolute methanol was added. The samples
were incubated at 25 degrees Celsius (°C) for 15 minutes,
the methanol was removed, and the samples were
allowed to dry overnight. Once dry, 65 μl of nuclease
free water was added and heated to 95°C for 30 minutes.
The samples were centrifuged and then stored at 4°C for
immediate use or stored at – 20°C for future use.
Detection of P. vivax by polymerase chain reaction
A species-specific PCR protocol was used to detect the
presence of P. vivax in the samples. PCR primers were
targeted to detect the P. vivax small subunit ribosomal
RNA gene and were able to detect low levels of parasites
[23]. The forward primer and reverse primer sequences
used were 50 GCAACGCTTCTAGCTTAATC 30 and
50ACAAGGACTTCCAAGCCGAAGC 30, respectively.
The PCR temperature protocol was as follows: 94°C for
5 minutes; 94°C for 30 seconds, 58°C for 30 seconds,
and 72°C for 60 seconds for 40 cycles; and 72°C for
10 minutes. The expected size of the amplicon was 131
base pairs (bps). All PCR runs included a P. vivax posi-
tive control obtained from the malaria reagents and
resources center (MR4).
PCR and sequencing of the DARC Gene
A PCR protocol was used to amplify a segment of the
DARC gene that was 329 bps and included the –46 T/C
SNP [14]. The forward primer and reverse primer se-
quences used were 50CAGGAAGACCCAAGGCCAG 30
and 50CCATGGCACCGTTTGGTTCAGG 30 respectively.
The PCR temperature protocol was as follows: 94°C for
5 min; 94°C for 20 seconds, 62°C for 15 seconds, and 72°C
for 20 seconds for 35 cycles; and 72°C for 10 minutes.
Ten of the samples from the malaria patients along with
a blood sample from one of the authors of European an-
cestry were sequenced for the GATA box mutation with
the forward and reverse primers described above to iden-
tify –46 T and –46C controls for use in the restriction
enzyme digestion of patient samples. DNA was sequenced
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by the Interdisciplinary Center for Biotechnology Research
at the University of Florida using Sanger sequencing. Se-
quence analysis was accomplished by the examination of
the chromatograms with 4Peaks (Mekentosj, Amsterdam,
NL) software followed by alignments using Clustal X2 [24].
Restriction fragment length polymorphism of DARC
Restriction fragment length polymorphism (RFLP) ana-
lysis was used to confirm the presence or absence of the
−46 T/C SNP [14]. The PCR products were digested over-
night with the restriction endonuclease Sty I (New England
Biolabs, Ipswich, MA) according to the manufacturer’s spe-
cifications. After heat inactivation of the enzyme for 10 min-
utes at 65°C, the fragments were stained with ethidium
bromide and resolved by gel electrophoresis on a 4% agar-
ose gel for 2.5 hours at 140 volts.
Results
The results from the GATA box mutation analysis and the
detection of P. vivax from the DBS are shown below
(Table 1). No cases of P. vivax were detected by PCR in
136 patient samples tested from the Blanchard clinic. Of
the samples tested for the FYES allele from the same clinic,
99.4% (163/164) had the FYES allele. Of the matched sam-
ples (n =99) tested for both the presence of P. vivax and
the FYES allele, no P. vivax infections were found and 99%
(98/99) had the FYES allele. The remaining samples from
the other sites were not tested (NT) for P. vivax, however
100% (20/20) were positive for the FYES allele.
Discussion
This preliminary study is the first in Haiti to focus on
the prevalence of the FYES allele and P. vivax infections
in malaria patients. No P. vivax infections were found
and 99% of the malaria patients had the FYES allele. The
frequency of the FYES allele observed in this study could
explain the different rates of P. vivax Haiti as compared
to Central and South America, where the majority of
infections are P. vivax and the population frequency of the
FYES allele is rare [17,25]. The results from this study are
Figure 1 Map of Haiti with clinical origin of dried blood spots.
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similar to other studies conducted in West African popu-
lations, who have between 95-100% prevalence of the FYES
allele and almost complete absence of P. vivax infections.
In a related study in Gambia (n = 1,176) where the popula-
tion had complete penetrance of the Duffy negative
phenotype, of the samples positive for the presence of
malaria parasites, 94.8% contained P. falciparum, 3.7%
contained P. malariae, 1.5% contained Plasmodium ovale,
and 0% contained P. vivax [21]. In another study from
nine countries in West and Central Africa (n = 2,588)
where the Duffy negative genotype is estimated to be
above 95%, PCR analysis of blood samples indicated that
of samples positive for malaria parasites, only a single case
of P. vivax was found while 98.5% contained P. falcip-
arum, 8.5% contained P. malariae, and 3.9% contained P.
ovale [9].
The high frequency of the FYES allele found in this study
could be attributed to the West African ancestry of Haitians.
Historical records dating back to the 1780s indicate that a
large proportion of West Africans brought to the New
World during the trans-Atlantic slave trade arrived in Haiti
[8]. It is estimated that over 75% of the total number of
enslaved Africans in Haiti came from West and West Cen-
tral Africa, which have almost exclusively the FYES/FYES
genotype [8,9]. This study found only a single patient with-
out the FYES allele that may be due to the small proportion
of Haitians having French and/or Spanish ancestry or a for-
eign aid worker, who have much lower population frequen-
cies of the FYES allele [18]. Though the French and the
Spanish originally colonized Haiti, in 1804 the French
departed and the remaining Spanish sequestered themselves
eastward to the Dominican Republic. This massive gene
flow from West Africa followed by the establishment of
Haiti as an independent country could have contributed to
high population frequency of Duffy negative individuals [8].
Although the sample size was relatively small, no P. vivax
DNA was found in any of the patient samples, which is
consistent with previous reports of the lack of P. vivax in
Haiti [2-4]. It is likely that the high prevalence of the FYES
allele that causes the Duffy negative phenotype may be re-
sponsible for the lack of P. vivax transmission in Haiti. The
samples in this study were obtained from areas that are
predominantly of West African ancestry, which are more
representative of the ancestry of native Haitians. However,
historical reports have indicated P. vivax transmission in
communes inhabited by higher proportions of people who
are of African/European descent that have lower popula-
tion frequencies of the Duffy negative phenotype [26].
Since P. vivax infections have received little attention, it is
unknown if such transmission is still occurring in those
areas of Haiti. It is likely that low rates of travelers to Haiti
from the surrounding P. vivax endemic countries in South
America may have slowed any potential introductions of P.
vivax infections into Haiti. Even if introductions were to
occur, it would not be likely that P. vivax transmission
could be sustained because of the high rates of the FYES al-
lele in the population. A more extensive study with a larger
sample size from multiple sites in Haiti is desirable to con-
firm these results.
In conclusion, no P. vivax infections were confirmed
by PCR and the FYES allele that results in silenced ex-
pression of the Duffy antigen on erythrocytes was found
in 99% of the patients. The high frequency of FYES allele
could explain the sparse historical evidence of P. vivax
infections in native Haitians and is attributable to their
West African ancestry. Though P. vivax malaria is not
prevalent and does not represent a significant public
health risk in native Haitians, the risk of infection for
travellers and foreign aid workers who are Duffy positive
remains uncertain.
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Table 1 Prevalence of GATA box mutations and P. vivax Infections
Site of sample (FYES) allele presence P. vivax presence
Collection No. tested No. positive % Positive No. tested No. positive
Blanchard Clinic 164 163 99.4 136 0
Hinche 7 7 100 0 NT*
Cap-Haitien 7 7 100 0 NT*
Jacmel 6 6 100 0 NT*
Total 184 99.5% 99.5% 136 0
*NT represents samples not tested for the presence of P. vivax.
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